Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

TG Therapeutics, Inc. - Common Stock (NQ: TGTX )

39.49 UNCHANGED
Streaming Delayed Price Updated: 4:15 PM EDT, Apr 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 657
Open 39.49
Bid (Size) 38.55 (3)
Ask (Size) 40.25 (4)
Prev. Close 39.49
Today's Range 39.49 - 39.49
52wk Range 12.93 - 43.32
Shares Outstanding 154,420,772
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Exploring high growth characteristics of TG THERAPEUTICS INC (NASDAQ:TGTX).
UA fundamental and technical analysis of (NASDAQ:TGTX): nlocking the high Growth Potential of TG THERAPEUTICS INC (NASDAQ:TGTX). 
Via Chartmill
Price Over Earnings Overview: TG Therapeutics
Via Benzinga

Performance

YTD
+27.14%
+27.14%
1 Month
-7.32%
-7.32%
3 Month
+35.52%
+35.52%
6 Month
+70.73%
+70.73%
1 Year
+177.12%
+177.12%

More News

Read More
Applying Mark Minervini’s growth stock checklist to TG THERAPEUTICS INC (NASDAQ:TGTX)
Via Chartmill
IBD 50 Stock TG Therapeutics Rallies On A Setback For Chief Rival Roche
Via Investor's Business Daily
Stock Of The Day: TG Therapeutics Breaks Out, May Head Higher
Via Benzinga
Why TG Therapeutics Stock Was Soaring This Week
Via The Motley Fool
Expert Outlook: TG Therapeutics Through The Eyes Of 5 Analysts
Via Benzinga
TG Therapeutics Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)
Via Benzinga
A Closer Look at TG Therapeutics's Options Market Dynamics
Via Benzinga
How does TG THERAPEUTICS INC (NASDAQ:TGTX) stack up against Mark Minervini’s strategy?
Via Chartmill
TG THERAPEUTICS INC (NASDAQ:TGTX), a growth stock which is not overvalued.
Via Chartmill
Bilibili, MARA And ZEEKR Are Among Top 8 Mid-Cap Gainers Last Week (Mar 3-Mar 7): Are The Others In Your Portfolio?
Via Benzinga
Retail Bets TG Therapeutics Stock Can Sustain Post-Earnings Gains Throughout The Week
Via Stocktwits
Stocks Pivot Lower On Trade Fears, Manufacturing Data
Via Talk Markets
Topics Stocks / Equities World Trade
Exposures Tariff
NASDAQ:TGTX stands out as a growth opportunity that won't break the bank.
Via Chartmill
TG Therapeutics, A New Leaderboard Stock, Skyrockets 17% On Sales Beat, Bullish Guide
Via Investor's Business Daily
Topics Earnings
Exposures Financial
Earnings Scheduled For March 3, 2025
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
8 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
What's Going On With TG Therapeutics Stock Tuesday?
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Stock Market Surges To Highs On Trump Election; Fed Cuts Rates, Palantir Soars: Weekly Review
Via Investor's Business Daily
Topics Economy Government
Exposures Interest Rates Political
TG Therapeutics Crashes — Reversing A Breakout — On Its Mixed Third-Quarter Results
Via Investor's Business Daily
Why Yum China Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Napco Security Technologies Posts Downbeat Results, Joins Centrus Energy, Constellation Energy And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.